Cipla stands strong with India in battle against COVID-19

21 Apr 2020 Evaluate
Cipla has set up Rs 25 crore ‘Caring for Life’ COVID-19 dedicated Fund to support the Indian Government’s efforts to effectively combat the COVID-19 pandemic. It includes contribution from employees towards this compassionate cause.

The company has implemented a spate of stringent safety measures in line with social distancing norms so that manufacturing and distribution of essential medicines can continue despite challenges of remote working. Employees have been working at manufacturing locations and depots, driven to uphold the interest of patients in these difficult times.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1505.60 6.50 (0.43%)
19-Dec-2025 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1746.05
Dr. Reddys Lab 1273.70
Cipla 1505.60
Zydus Lifesciences 913.05
Lupin 2117.45
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×